vs
CITY HOLDING CO（CHCO）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
CITY HOLDING CO的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.1倍（$80.2M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 11.8%），CITY HOLDING CO自由现金流更多（$128.4M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 5.3%）
Jam City是一家总部位于美国加州卡尔弗城的电子游戏开发及发行商，由克里斯·德沃尔夫等四人于2010年联合创立。目前公司在美、加、南美及欧洲共设有9个工作室，2021年时员工规模达825人，最大股东为网石。截至2021年，旗下游戏月活用户达3100万，累计总下载量超13亿次。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CHCO vs PBYI — 直观对比
营收规模更大
CHCO
是对方的1.1倍
$75.5M
营收增速更快
PBYI
高出15.9%
11.8%
自由现金流更多
CHCO
多$114.1M
$14.4M
两年增速更快
PBYI
近两年复合增速
5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $80.2M | $75.5M |
| 净利润 | $31.6M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 49.3% | 22.7% |
| 净利率 | 39.4% | — |
| 营收同比 | 11.8% | 27.7% |
| 净利润同比 | 10.2% | — |
| 每股收益（稀释后） | $2.17 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CHCOPBYI
| Q4 25 | $80.2M | $75.5M | ||
| Q3 25 | $81.3M | $54.5M | ||
| Q2 25 | $78.2M | $52.4M | ||
| Q1 25 | $74.6M | $46.0M | ||
| Q4 24 | $71.7M | $59.1M | ||
| Q3 24 | $76.0M | $80.5M | ||
| Q2 24 | $73.5M | $47.1M | ||
| Q1 24 | $72.4M | $43.8M |
净利润CHCOPBYI
| Q4 25 | $31.6M | — | ||
| Q3 25 | $35.2M | $8.8M | ||
| Q2 25 | $33.4M | $5.9M | ||
| Q1 25 | $30.3M | $3.0M | ||
| Q4 24 | $28.7M | — | ||
| Q3 24 | $29.8M | $20.3M | ||
| Q2 24 | $29.1M | $-4.5M | ||
| Q1 24 | $29.5M | $-4.8M |
毛利率CHCOPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率CHCOPBYI
| Q4 25 | 49.3% | 22.7% | ||
| Q3 25 | 54.0% | 17.6% | ||
| Q2 25 | 52.7% | 12.7% | ||
| Q1 25 | 49.5% | 8.7% | ||
| Q4 24 | 48.1% | 22.6% | ||
| Q3 24 | 48.9% | 27.4% | ||
| Q2 24 | 49.3% | -4.6% | ||
| Q1 24 | 50.6% | -5.3% |
净利率CHCOPBYI
| Q4 25 | 39.4% | — | ||
| Q3 25 | 43.3% | 16.2% | ||
| Q2 25 | 42.7% | 11.2% | ||
| Q1 25 | 40.7% | 6.5% | ||
| Q4 24 | 40.0% | — | ||
| Q3 24 | 39.2% | 25.2% | ||
| Q2 24 | 39.6% | -9.6% | ||
| Q1 24 | 40.8% | -11.0% |
每股收益（稀释后）CHCOPBYI
| Q4 25 | $2.17 | $0.26 | ||
| Q3 25 | $2.41 | $0.17 | ||
| Q2 25 | $2.29 | $0.12 | ||
| Q1 25 | $2.06 | $0.06 | ||
| Q4 24 | $1.94 | $0.40 | ||
| Q3 24 | $2.02 | $0.41 | ||
| Q2 24 | $1.96 | $-0.09 | ||
| Q1 24 | $1.97 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $191.9M | $97.5M |
| 总债务越低越好 | $150.0M | $22.7M |
| 股东权益账面价值 | $809.7M | $130.3M |
| 总资产 | $6.7B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.19× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CHCOPBYI
| Q4 25 | $191.9M | $97.5M | ||
| Q3 25 | $225.6M | $94.4M | ||
| Q2 25 | $172.1M | $96.0M | ||
| Q1 25 | $384.7M | $93.2M | ||
| Q4 24 | $225.4M | $101.0M | ||
| Q3 24 | $293.9M | $96.7M | ||
| Q2 24 | $218.0M | $96.8M | ||
| Q1 24 | $318.7M | $107.2M |
总债务CHCOPBYI
| Q4 25 | $150.0M | $22.7M | ||
| Q3 25 | $150.0M | $34.0M | ||
| Q2 25 | $150.0M | $45.3M | ||
| Q1 25 | $150.0M | $56.7M | ||
| Q4 24 | $150.0M | $68.0M | ||
| Q3 24 | $150.0M | $79.3M | ||
| Q2 24 | $150.0M | $90.7M | ||
| Q1 24 | $150.0M | $102.0M |
股东权益CHCOPBYI
| Q4 25 | $809.7M | $130.3M | ||
| Q3 25 | $798.9M | $115.3M | ||
| Q2 25 | $764.2M | $104.7M | ||
| Q1 25 | $756.3M | $97.1M | ||
| Q4 24 | $730.7M | $92.1M | ||
| Q3 24 | $741.3M | $71.1M | ||
| Q2 24 | $686.7M | $48.5M | ||
| Q1 24 | $682.2M | $51.0M |
总资产CHCOPBYI
| Q4 25 | $6.7B | $216.3M | ||
| Q3 25 | $6.7B | $202.9M | ||
| Q2 25 | $6.6B | $194.9M | ||
| Q1 25 | $6.6B | $196.2M | ||
| Q4 24 | $6.5B | $213.3M | ||
| Q3 24 | $6.4B | $220.7M | ||
| Q2 24 | $6.3B | $205.0M | ||
| Q1 24 | $6.3B | $214.1M |
负债/权益比CHCOPBYI
| Q4 25 | 0.19× | 0.17× | ||
| Q3 25 | 0.19× | 0.30× | ||
| Q2 25 | 0.20× | 0.43× | ||
| Q1 25 | 0.20× | 0.58× | ||
| Q4 24 | 0.21× | 0.74× | ||
| Q3 24 | 0.20× | 1.12× | ||
| Q2 24 | 0.22× | 1.87× | ||
| Q1 24 | 0.22× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $131.4M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $128.4M | $14.4M |
| 自由现金流率自由现金流/营收 | 160.2% | 19.1% |
| 资本支出强度资本支出/营收 | 3.6% | 0.0% |
| 现金转化率经营现金流/净利润 | 4.16× | — |
| 过去12个月自由现金流最近4个季度 | $223.3M | $41.7M |
8季度趋势，按日历期对齐
经营现金流CHCOPBYI
| Q4 25 | $131.4M | $14.4M | ||
| Q3 25 | $37.3M | $9.7M | ||
| Q2 25 | $28.2M | $14.1M | ||
| Q1 25 | $31.5M | $3.6M | ||
| Q4 24 | $131.9M | $15.6M | ||
| Q3 24 | $37.6M | $11.0M | ||
| Q2 24 | $28.3M | $1.0M | ||
| Q1 24 | $32.2M | $11.2M |
自由现金流CHCOPBYI
| Q4 25 | $128.4M | $14.4M | ||
| Q3 25 | $35.8M | $9.7M | ||
| Q2 25 | $27.8M | $14.1M | ||
| Q1 25 | $31.3M | $3.6M | ||
| Q4 24 | $129.2M | $15.6M | ||
| Q3 24 | $37.0M | $11.0M | ||
| Q2 24 | $27.8M | $1.0M | ||
| Q1 24 | $31.6M | — |
自由现金流率CHCOPBYI
| Q4 25 | 160.2% | 19.1% | ||
| Q3 25 | 44.0% | 17.7% | ||
| Q2 25 | 35.6% | 26.8% | ||
| Q1 25 | 41.9% | 7.7% | ||
| Q4 24 | 180.2% | 26.4% | ||
| Q3 24 | 48.7% | 13.7% | ||
| Q2 24 | 37.8% | 2.1% | ||
| Q1 24 | 43.6% | — |
资本支出强度CHCOPBYI
| Q4 25 | 3.6% | 0.0% | ||
| Q3 25 | 1.9% | 0.0% | ||
| Q2 25 | 0.5% | 0.0% | ||
| Q1 25 | 0.3% | 0.1% | ||
| Q4 24 | 3.8% | 0.0% | ||
| Q3 24 | 0.9% | 0.0% | ||
| Q2 24 | 0.7% | 0.0% | ||
| Q1 24 | 0.8% | 0.0% |
现金转化率CHCOPBYI
| Q4 25 | 4.16× | — | ||
| Q3 25 | 1.06× | 1.10× | ||
| Q2 25 | 0.85× | 2.41× | ||
| Q1 25 | 1.04× | 1.21× | ||
| Q4 24 | 4.60× | — | ||
| Q3 24 | 1.26× | 0.54× | ||
| Q2 24 | 0.97× | — | ||
| Q1 24 | 1.09× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
